ABSTRACT Preleukemic bone marrow and spleen cells of irradiated C57BL/6 mice that were inoculated with the radiation-induced leukemia virus variant D-RadLV differ from autonomous end-stage leukemia cells in the expression of the receptor for peanut agglutinin. As a result, the preleukemic cells are agglutinated by peanut agglutinin and the end-stage cells are not. This observation provides further evidence that preleukemic cells possess surface markers similar to those of the prothymocyte. In vitro and in vivo thymocyte-virus interactions reveal that cells susceptible to D-RadLV transformation are present mainly among the peanut agglutinin-receptorbearing thymocyte population which has previously been demonstrated to be immunologically immature.
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A high proportion of irradiated C57BL/6 mice inoculated with the radiation leukemia virus variant D-RadLV develop T-cell leukemias (1) . These leukemic cells have the phenotype of the minor thymus subpopulation, expressing high levels of H-2 alloantigen and relatively low levels of Thy-i (2) . In contrast, preleukemic cells that have the potential to develop into leukemic cells after transplantation into the appropriate recipient mice are present in the bone marrow shortly after intrathymic D-RadLV inoculation (3) and have the characteristics of prothymocytes, lacking the Thy-I cell surface differentiation antigen (4) . Besides this difference in acquisition of the antigen, preleukemic cells also have been found to differ from leukemic cells in their immunizing capacity and in the specific environmental requirements needed for their further proliferation into T-cell leukemias (4, 5 ).
Here we demonstrate that preleukemic cells differ from leukemic cells by the expression of an additional surface marker, the receptor for peanut agglutinin (PNA), as a result of which the former cells are agglutinated by PNA (PNA+) and the latter are not (PNA- Transplantation Bioassay. Leukemogenic potential of cell suspensions was tested by the transplantation bioassay method of Haran-Ghera (10).
Leukemia Induction. Preleukemic cells were induced by injecting D-RadLV into the thymus of C57BL/6 mice 6-8 weeks old. The virus preparation and technical procedures are described elsewhere (1). End-stage leukemia cells were obtained from thymuses (thymomas) 140-400 days after virus inoculation.
RESULTS AND DISCUSSION
It has recently been shown that PNA, a lectin specific for Dgalactosyl-4(1--3)-N-acetyl-D-galactosamine, binds specifically to immature mouse thymocytes (7) as well as to hemopoietic stem cells present among murine bone marrow and spleen cells (8) . Mature lymphocytes do not bind the lectin because the receptor is masked by sialic acid. These findings suggested that preleukemic cells having the characteristics of committed precursor T cells may also possess the PNA receptors on their surfaces, whereas on leukemic cells bearing the phenotype characteristics of mature T cells the receptor may be masked by sialic acid and thus be refractory to PNA-induced agglutination (PNA-).
We have compared the agglutination by PNA of DRadLV-induced leukemic thymocytes (1) (2 X 107 cells in 2 ml of Pi/NaCl plus 1.5 mg of PNA per 0.4 ml of Pi/NaCl) to that of thymocytes and cortisone-resistant thymocytes of normal mice under the same conditions. The total normal unseparated thymocyte population, consisting mainly of immature T cells, was strongly agglutinated, whereas the leukemic thymocytes and the hydrocortisone-resistant thymocytes were not agglutinated by PNA (Fig. 1) The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. commonly accepted notion that tumor cells are more agglutinable than are their normal counterparts (11, 12) .
The agglutination properties of the preleukemic cells could not be examined directly because as yet there is no method for the isolation of these cells. We therefore fractionated bone marrow and spleen cells (among which preleukemic cells are the most abundant in D-RadLV-inoculated mice) by agglutination with PNA and tested their leukemogenic potential by using the transplantation bioassay method.
The same number (107 cells) of unseparated, PNA+, and PNA-bone marrow cells collected from C57BL/6 mice previously inoculated with D-RadLV or Pi/NaCl (the solution used for virus preparation) were injected intravenously into (BALB/c X C57BL/6)F1 mice, 1-3 hr after they were exposed to 400 R (0.1 coulomb/kg) of whole-body irradiation (a nonleukemogenic-dose that facilitates the proliferation of the injected cells pacity to induce leukemia was tested by using the above mentioned transplantation bioassay method. The in vitro experiment involved separation of normal C57BL/6 thymocytes by PNA (7) and incubation of the PNA+ or PNA-thymocytes with D-RadLV for 60 min at room temperature. After repeated washings (three times with 5 ml of Pi/NaCl), the cells were injected into F1 irradiated recipients and leukemia induction in the recipients was observed. The results (Table 1) show that cells susceptible to D-RadLV transformation (yielding a majority of leukemias of donor origin) were present mainly among the PNA+ thymocytes.
Because PNA reacts preferentially with immature lymphocytes (7, 8, (13) (14) (15) (16) , our results provide additional evidence on the immature character of the preleukemic cells.
In conclusion, our findings demonstrate that the transformed cells present during the two distinct phases in D-RadLV leukemogenesis (5)-the dependent phase represented by preleukemic cells and the autonomous phase involving transition to leukemic cells-differ in their agglutinability by PNA.
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